Rafferty Asset Management, LLC Replimune Group, Inc. Transaction History

Rafferty Asset Management, LLC

$27.6 Billion
Q4 2024

A detailed history of Rafferty Asset Management, LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 77,308 shares of REPL stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,308

Previous 101,214 23.62%

Holding current value

$1.05 Million

Previous $1.11 Million 15.6%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$10.54 - $14.93 $251,969 - $356,916	-23,906 Reduced 23.62%	77,308 $936,000
Q3 2024 Nov 13, 2024	BUY	$8.09 - $11.23 $818,821 - $1.14 Million	101,214 New	101,214 $1.11 Million
Q1 2024 May 13, 2024	BUY	$6.87 - $9.31 $1.23 Million - $1.66 Million	178,681 Added 38.56%	642,078 $5.25 Million
Q4 2023 Feb 13, 2024	BUY	$6.75 - $16.18 $1.87 Million - $4.48 Million	276,596 Added 148.07%	463,397 $3.91 Million
Q3 2023 Nov 13, 2023	BUY	$15.96 - $22.18 $672,059 - $933,977	42,109 Added 29.1%	186,801 $3.2 Million
Q2 2023 Aug 11, 2023	SELL	$15.65 - $24.1 $1.13 Million - $1.73 Million	-71,987 Reduced 33.22%	144,692 $3.36 Million
Q1 2023 May 11, 2023	BUY	$17.48 - $29.09 $2.48 Million - $4.12 Million	141,789 Added 189.33%	216,679 $3.83 Million
Q4 2022 Feb 13, 2023	BUY	$17.09 - $27.91 $12,697 - $20,737	743 Added 1.0%	74,890 $2.04 Million
Q3 2022 Nov 14, 2022	BUY	$15.6 - $21.15 $269,302 - $365,112	17,263 Added 30.35%	74,147 $1.28 Million
Q2 2022 Aug 12, 2022	SELL	$13.32 - $19.98 $580,046 - $870,069	-43,547 Reduced 43.36%	56,884 $994,000
Q1 2022 May 13, 2022	BUY	$15.24 - $29.75 $488,320 - $953,249	32,042 Added 46.85%	100,431 $1.71 Million
Q4 2021 Feb 10, 2022	BUY	$25.43 - $34.25 $153,012 - $206,082	6,017 Added 9.65%	68,389 $1.85 Million
Q3 2021 Nov 10, 2021	SELL	$28.98 - $39.54 $175,473 - $239,414	-6,055 Reduced 8.85%	62,372 $1.85 Million
Q2 2021 Aug 10, 2021	SELL	$28.5 - $39.37 $843,742 - $1.17 Million	-29,605 Reduced 30.2%	68,427 $2.63 Million
Q1 2021 May 10, 2021	BUY	$30.22 - $45.57 $2.45 Million - $3.69 Million	81,083 Added 478.39%	98,032 $2.99 Million
Q4 2020 Feb 10, 2021	BUY	$23.5 - $52.65 $398,301 - $892,364	16,949 New	16,949 $647,000

Others Institutions Holding REPL

# of Institutions

161

Shares Held

74.9M

Call Options Held

38.4K

Put Options Held

43.7K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $671M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Replimune Group, Inc. Transaction History